ESSA Pharma Financial Health

Short Term Liabilities: EPIX's short term assets ($169.1M) exceed its short term liabilities ($2.3M).

Long Term Liabilities: EPIX's short term assets ($169.1M) exceed its long term liabilities ($76.4K).

Debt Level: EPIX is debt free.

Reducing Debt: EPIX currently has no debt however we can't compare to 5 years ago as we have no data for that period.

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: EPIX has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: EPIX has sufficient cash runway for 2 years if free cash flow continues to reduce at historical rates of 12.9% each year.

• Healthy companies in the Pharmaceuticals & Biotech industry.